<DOC>
	<DOCNO>NCT01789918</DOCNO>
	<brief_summary>The ACHIEVE study single-arm , open-label , prospective , post-market follow-up study include one hundred ( 100 ) eligible patient define within clinical investigational plan , twelve month follow-up period . The ACHIEVE study originally design accordance 2007 ESH ESC guideline resistant hypertension .</brief_summary>
	<brief_title>TrAnsCatHeter Intravascular Ultrasound Energy deliVery rEnal Denervation ( ACHIEVE )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Resistant hypertension , defined 2007 ESHESC guideline 18 year age older Negative pregnancy test female patient childbearing potential Willing able comply followup requirement Signed informed consent Secondary hypertension Main renal artery length &lt; 20 mm Main renal artery diameter &lt; 4 mm Renal artery stenosis Iliac/femoral artery stenosis preclude insertion catheter Untreated allergy contrast medium Currently participate study investigational drug device Moderate severe renal insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Renal denervation</keyword>
</DOC>